Literature DB >> 22080861

Unraveling the functional implications of GWAS: how T cell protein tyrosine phosphatase drives autoimmune disease.

Julie Zikherman1, Arthur Weiss.   

Abstract

Genome-wide association studies (GWAS) have identified a large number of SNPs that are linked to human autoimmune diseases. However, the functional consequences of most of these genetic variations remain undefined. T cell protein tyrosine phosphatase (TCPTP, which is encoded by PTPN2) is a JAK/STAT and growth factor receptor phosphatase that has been linked to the pathogenesis of type 1 diabetes, rheumatoid arthritis, and Crohn's disease by GWAS. In this issue of the JCI, Wiede and colleagues have generated a T cell-specific deletion of TCPTP and identified a novel role for this phosphatase as a negative regulator of TCR signaling. These data provide new insight as to how noncoding PTPN2 SNPs identified in GWAS could drive human autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22080861      PMCID: PMC3226009          DOI: 10.1172/JCI60001

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus.

Authors:  Naohito Aoki; Tsukasa Matsuda
Journal:  Mol Endocrinol       Date:  2002-01

2.  The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3.

Authors:  Paul D Simoncic; Ailsa Lee-Loy; Dwayne L Barber; Michel L Tremblay; C Jane McGlade
Journal:  Curr Biol       Date:  2002-03-19       Impact factor: 10.834

3.  T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice.

Authors:  Florian Wiede; Benjamin J Shields; Sock Hui Chew; Konstantinos Kyparissoudis; Catherine van Vliet; Sandra Galic; Michel L Tremblay; Sarah M Russell; Dale I Godfrey; Tony Tiganis
Journal:  J Clin Invest       Date:  2011-11-14       Impact factor: 14.808

4.  Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE.

Authors:  Chieko Kyogoku; Carl D Langefeld; Ward A Ortmann; Annette Lee; Scott Selby; Victoria E H Carlton; Monica Chang; Paula Ramos; Emily C Baechler; Franak M Batliwalla; Jill Novitzke; Adrienne H Williams; Clarence Gillett; Peter Rodine; Robert R Graham; Kristin G Ardlie; Patrick M Gaffney; Kathy L Moser; Michelle Petri; Ann B Begovich; Peter K Gregersen; Timothy W Behrens
Journal:  Am J Hum Genet       Date:  2004-07-23       Impact factor: 11.025

5.  A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.

Authors:  Nunzio Bottini; Lucia Musumeci; Andres Alonso; Souad Rahmouni; Konstantina Nika; Masoud Rostamkhani; James MacMurray; Gian Franco Meloni; Paola Lucarelli; Maurizio Pellecchia; George S Eisenbarth; David Comings; Tomas Mustelin
Journal:  Nat Genet       Date:  2004-03-07       Impact factor: 38.330

6.  T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease.

Authors:  Krista M Heinonen; Frederick P Nestel; Evan W Newell; Gabrielle Charette; Thomas A Seemayer; Michel L Tremblay; Wayne S Lapp
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

7.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Authors:  Ann B Begovich; Victoria E H Carlton; Lee A Honigberg; Steven J Schrodi; Anand P Chokkalingam; Heather C Alexander; Kristin G Ardlie; Qiqing Huang; Ashley M Smith; Jill M Spoerke; Marion T Conn; Monica Chang; Sheng-Yung P Chang; Randall K Saiki; Joseph J Catanese; Diane U Leong; Veronica E Garcia; Linda B McAllister; Douglas A Jeffery; Annette T Lee; Franak Batliwalla; Elaine Remmers; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Christopher I Amos; John J Sninsky; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

8.  PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells.

Authors:  Kiminori Hasegawa; Flavius Martin; Guangming Huang; Dan Tumas; Lauri Diehl; Andrew C Chan
Journal:  Science       Date:  2004-01-30       Impact factor: 47.728

9.  Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice.

Authors:  K E You-Ten; E S Muise; A Itié; E Michaliszyn; J Wagner; S Jothy; W S Lapp; M L Tremblay
Journal:  J Exp Med       Date:  1997-08-29       Impact factor: 14.307

10.  Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase.

Authors:  J F Cloutier; A Veillette
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

View more
  13 in total

Review 1.  Can rheumatoid arthritis be prevented?

Authors:  Kevin D Deane
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-10-02       Impact factor: 4.098

2.  Efficient CRISPR/Cas9 Disruption of Autoimmune-Associated Genes Reveals Key Signaling Programs in Primary Human T Cells.

Authors:  Warren Anderson; Jerill Thorpe; S Alice Long; David J Rawlings
Journal:  J Immunol       Date:  2019-11-13       Impact factor: 5.422

Review 3.  Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis.

Authors:  William P Arend; Gary S Firestein
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

Review 4.  Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE.

Authors:  Kevin D Deane; Hani El-Gabalawy
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

5.  PTPN2 improved renal injury and fibrosis by suppressing STAT-induced inflammation in early diabetic nephropathy.

Authors:  Ya Li; Huimin Zhou; Yulin Li; Lu Han; Ming Song; Fangfang Chen; Guokai Shang; Di Wang; Zhihao Wang; Wei Zhang; Ming Zhong
Journal:  J Cell Mol Med       Date:  2019-04-06       Impact factor: 5.310

6.  Identification of the tyrosine-protein phosphatase non-receptor type 2 as a rheumatoid arthritis susceptibility locus in europeans.

Authors:  Joanna E Cobb; Darren Plant; Edward Flynn; Meriem Tadjeddine; Philippe Dieudé; François Cornélis; Lisbeth Ärlestig; Solbritt Rantapää Dahlqvist; George Goulielmos; Dimitrios T Boumpas; Prodromos Sidiropoulos; Sophine B Krintel; Lykke M Ørnbjerg; Merete L Hetland; Lars Klareskog; Thomas Haeupl; Andrew Filer; Christopher D Buckley; Karim Raza; Torsten Witte; Reinhold E Schmidt; Oliver FitzGerald; Douglas Veale; Stephen Eyre; Jane Worthington
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

7.  Network analysis identifies protein clusters of functional importance in juvenile idiopathic arthritis.

Authors:  Adam Stevens; Stefan Meyer; Daniel Hanson; Peter Clayton; Rachelle P Donn
Journal:  Arthritis Res Ther       Date:  2014-05-08       Impact factor: 5.156

8.  The tyrosine phosphatase PTPN22 discriminates weak self peptides from strong agonist TCR signals.

Authors:  Robert J Salmond; Rebecca J Brownlie; Vicky L Morrison; Rose Zamoyska
Journal:  Nat Immunol       Date:  2014-08-10       Impact factor: 25.606

9.  Role of PTPN2/22 polymorphisms in pathophysiology of Crohn's disease.

Authors:  Robert C Sharp; Shazia A Beg; Saleh A Naser
Journal:  World J Gastroenterol       Date:  2018-02-14       Impact factor: 5.742

10.  An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes.

Authors:  Fabiana Paladini; Maria Teresa Fiorillo; Carolina Vitulano; Valentina Tedeschi; Matteo Piga; Alberto Cauli; Alessandro Mathieu; Rosa Sorrentino
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.